JACC Heart Fail 12 , 18141826 (2024)
Healthcare professionals increasingly recognize obesity as a chronic medical condition requiring long-term management instead of temporary dieting approaches
The reduced appetite that comes with semaglutide is real, and studies commonly report weight loss in the region of 5 to 15 percent of body weight over about a year, though results vary from person to person
Figure 1: Changes in Body Weight (%) from Baseline to Week 72 in Study 1 in Patients with Obesity or Overweight (without Type 2 Diabetes) Note: Based on average percent weight change of each randomized patient within each specific treatment arm from 100 imputed datasets including observed data and imputed data using hybrid approach for missing values
At the doses present in Empower formulations, niacinamide provides modest supplementation that may support mitochondrial function and energy metabolism
Acute pancreatitis typically causes severe abdominal pain, nausea, and vomiting, whilst chronic pancreatitis may lead to persistent digestive problems and diabetes